Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVANAFIL vs AVIBACTAM\CEFTAZIDIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVANAFIL vs AVIBACTAM\CEFTAZIDIME: Safety Overview

Metric AVANAFIL AVIBACTAM\CEFTAZIDIME
Total FAERS Reports 537 1,655
Deaths Reported 4 567
Death Rate 0.7% 34.3%
Hospitalizations 26 515
Average Patient Age 64.2 yrs 56.8 yrs
% Female Patients 0.2% 35.4%
FDA Approval Date Apr 27, 2012 N/A
Manufacturer Camber Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A